Creative Medical Technology Holdings (CELZ) Ratios
Creative Medical Technology Holdings Ratios
CELZ's free cash flow for Q2 2026 was $-1.47M. For the 2026 fiscal year, CELZ's free cash flow was increased by $0.00 and operating cash flow was $-1.47M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 25.97 | 18.73 | 27.65 | 5.64 | 10.22 |
| Quick Ratio | 25.97 | 18.72 | 27.64 | 5.64 | 10.21 |
| Cash Ratio | 25.30 | 18.13 | 9.33 | 2.50 | 10.21 |
| Solvency Ratio | -20.61 | -16.43 | -13.98 | -3.03 | 18.38 |
| Operating Cash Flow Ratio | -20.56 | -16.18 | -21.62 | -2.35 | -2.11 |
| Short-Term Operating Cash Flow Coverage | -412.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 7.11M | $ 5.81M | $ 9.90M | $ 15.43M | $ 9.69M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.05 | 1.04 | 1.21 | 1.10 |
| Debt Service Coverage Ratio | -424.09 | 0.00 | 0.00 | 0.00 | 5.51 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.73 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.00 | 0.00 | 16.42 |
| Net Debt to EBITDA | 1.20 | 1.10 | 0.63 | 0.82 | -0.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 63.43% | 60.00% | 60.00% | 67.84% | 45.36% |
| EBIT Margin | -102380.23% | -49940.74% | -62445.91% | -11562.50% | 26768.24% |
| EBITDA Margin | -100324.78% | -48936.63% | -61394.98% | -11458.56% | 26873.17% |
| Operating Profit Margin | -102380.23% | -52216.92% | -62445.91% | -11562.50% | -3562.17% |
| Pretax Profit Margin | -99916.80% | -49940.74% | -58739.71% | -11449.26% | 21892.75% |
| Net Profit Margin | -99916.80% | -49940.74% | -58739.71% | -11449.26% | 21892.75% |
| Continuous Operations Profit Margin | -99916.80% | -49940.74% | -58739.71% | -11449.26% | 21892.75% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 97.59% | 95.64% | 94.06% | 99.02% | -614.59% |
| Return on Assets (ROA) | -76.77% | -82.37% | -49.34% | -52.87% | 170.50% |
| Return on Equity (ROE) | -79.78% | -86.63% | -51.11% | -63.94% | 188.02% |
| Return on Capital Employed (ROCE) | -81.64% | -90.58% | -54.33% | -64.57% | -30.59% |
| Return on Invested Capital (ROIC) | -81.48% | -90.58% | -54.33% | -64.57% | -30.59% |
| Return on Tangible Assets | -80.99% | -89.49% | -51.45% | -54.10% | 178.87% |
| Earnings Yield | -128.37% | -160.64% | -81.47% | -243.55% | 333.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.12 | 0.00 | 0.00 | 0.00 | 35.31 |
| Payables Turnover | 0.01 | 0.02 | 0.01 | 0.01 | 0.06 |
| Inventory Turnover | 0.00 | 2.01 | 0.55 | 2.79 | 4.41 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.01 | -0.01 |
| Cash Conversion Cycle | -41863.64 | -22508.55 | -31500.11 | -41730.04 | -5706.44 |
| Days of Sales Outstanding | 3168.44 | 0.00 | 0.00 | 0.00 | 10.34 |
| Days of Inventory Outstanding | 0.00 | 182.00 | 668.56 | 130.60 | 82.71 |
| Days of Payables Outstanding | 45032.08 | 22690.56 | 32168.67 | 41860.64 | 5799.49 |
| Operating Cycle | 3168.44 | 182.00 | 668.56 | 130.60 | 93.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.46 | -3.58 | -5.70 | -7.13 | -8.51 |
| Free Cash Flow Per Share | -2.46 | -3.58 | -5.77 | -7.13 | -8.51 |
| Dividend Paid and CapEx Coverage Ratio | -1171289.00 | 0.00 | -80.28 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -1171289.00 | 0.00 | -80.28 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -412.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -976.07 | -481.94 | -891.99 | -88.00 | -25.25 |
| Free Cash Flow Yield | -125.40% | -155.02% | -125.25% | -187.20% | -38.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.78 | -0.62 | -1.23 | -0.41 | 0.30 |
| Price-to-Sales (P/S) Ratio | 778.38 | 310.89 | 721.02 | 47.01 | 65.61 |
| Price-to-Book (P/B) Ratio | 0.62 | 0.54 | 0.63 | 0.26 | 0.56 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.80 | -0.65 | -0.80 | -0.53 | -2.60 |
| Price-to-Operating Cash Flow Ratio | -0.80 | -0.65 | -0.81 | -0.53 | -2.60 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.47 | 0.02 | 0.00 | -0.00 |
| Enterprise Value Multiple | 0.42 | 0.47 | -0.55 | 0.41 | -0.21 |
| Enterprise Value | -2.52M | -2.52M | 3.02M | -4.16M | -4.97M |
| EV to EBITDA | 0.42 | 0.47 | -0.55 | 0.41 | -0.21 |
| EV to Sales | -420.61 | -229.15 | 335.81 | -46.90 | -56.60 |
| EV to Free Cash Flow | 0.43 | 0.48 | -0.37 | 0.53 | 2.24 |
| EV to Operating Cash Flow | 0.43 | 0.48 | -0.38 | 0.53 | 2.24 |
| Tangible Book Value Per Share | 2.99 | 3.93 | 7.04 | 14.11 | 37.20 |
| Shareholders’ Equity Per Share | 3.15 | 4.28 | 7.35 | 14.51 | 39.22 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.01 | 0.01 | 0.08 | 0.34 |
| Net Income Per Share | -2.52 | -3.71 | -3.76 | -9.28 | 73.75 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.98 | 1.00 | 0.94 | 0.99 | 0.82 |
| Research & Development to Revenue | 376.63 | 218.25 | 218.96 | 70.75 | 1.24 |
| SG&A to Revenue | 627.25 | 294.48 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.58 | 3.33 | 4.07 | 0.78 | 6.78 |
| Income Quality | 0.98 | 0.97 | 1.52 | 0.77 | -0.12 |
Currency in USD
